Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/19/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong John Pagel?

John M. Pagel

Clinical Hematologist, Staff Physician

Swedish Cancer Institute

HQ Phone:  (206) 215-6800

Direct Phone: (206) ***-****direct phone

Email: j***@***.org

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Swedish Cancer Institute

1221 Madison St. Arnold Pavilion, Suite 200

Seattle, Washington,98104

United States

Company Description

The Swedish Cancer Institute (SCI) opened in 1932 as the first dedicated cancer-care center west of the Mississippi River. It is the largest and most comprehensive cancer treatment program in the Pacific Northwest, caring for more people with more types of can... more

Find other employees at this company (6,294)

Background Information

Employment History

Owner Manager

Pagel's Ponderosa Dairy LLC


Affiliations

Actinium Pharmaceuticals , Inc.

Advisory Board Member


Fred Hutchinson Cancer Research Center

Associate Member, Clinical Research Division


Fred Hutchinson Cancer Research Center

Associate Member, Clinical Research Division


Risk Management Not Supply Management

Founder


The Center for Biomedical Continuing Education

Advisory Board Member


Northwest Technical College

Member, Ag Advisory Committee


Education

BA

Biology

University of California


M.D.


MD

Swedish Cancer Institute


MD

University of Washington School of Medicine


Ph.D.

Microbiology and Molecular Genetics

University of California


bachelor of science

UCLA


medical degree

Boston University School of Medicine


Web References(108 Total References)


Clinical Advisory Board | Actinium Pharmaceuticals

www.actiniumpharma.com [cached]

John M. Pagel, M.D., Ph.D. (Chair),
Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington School of Medicine, Seattle, WA Swedish Cancer Institute, Seattle, WA Dr. Pagel is an Associate Professor of Medical Oncology and Associate Member in the Clinical Research Division of FHCRC. He received a PhD in microbiology and molecular genetics from the University of California, Irvine and his MD (magna cum laude) from Boston University School of Medicine. After a Post-doctoral as a Dr. Pagel also serves as Chief of the Hematologic Malignancies Program at the Swedish Cancer Institute. Dr. Pagel specializes in bone marrow transplant, leukemia and lymphoma and has received numerous awards, including the ASCO Young Investigator Award, Lymphoma Research Foundation Career Development Award, ASCO Career Development Award, University of California President's Award, and a Howard Hughes Post-Doctoral Research Award. Throughout his career, Dr. Pagel has published many abstracts and articles in a variety of publications, including Blood, Bone Marrow Transplantation, and the Proceedings of the National Academy of Sciences. He leads a number of studies of radioimmunotherapy as the principal investigator of leukemia clinical trials. Dr. Pagel has been instrumental in the historical development of the anti-CD45 antibody, which when radiolabeled with


www.actiniumpharma.com

John M. Pagel, M.D., Ph.D. (Chair),
Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington School of Medicine, Seattle, WA Swedish Cancer Institute, Seattle, WA Dr. Pagel is an Associate Professor of Medical Oncology and Associate Member in the Clinical Research Division of FHCRC. He received a PhD in microbiology and molecular genetics from the University of California, Irvine and his MD (magna cum laude) from Boston University School of Medicine. After a Post-doctoral as a Dr. Pagel also serves as Chief of the Hematologic Malignancies Program at the Swedish Cancer Institute. Dr. Pagel specializes in bone marrow transplant, leukemia and lymphoma and has received numerous awards, including the ASCO Young Investigator Award, Lymphoma Research Foundation Career Development Award, ASCO Career Development Award, University of California President's Award, and a Howard Hughes Post-Doctoral Research Award. Throughout his career, Dr. Pagel has published many abstracts and articles in a variety of publications, including Blood, Bone Marrow Transplantation, and the Proceedings of the National Academy of Sciences. He leads a number of studies of radioimmunotherapy as the principal investigator of leukemia clinical trials. Dr. Pagel has been instrumental in the historical development of the anti-CD45 antibody, which when radiolabeled with


BioMedical Learning Institute

biomedicallearning.com [cached]

John M. Pagel, MD, PhD Dsc
John M. Pagel, MD, PhD Dsc Clinical Hematologist Staff Physician Swedish Cancer Institute Dr. Pagel John M. Pagel, MD, PhD Dsc Clinical Hematologist Staff Physician Swedish Cancer Institute


How These Biotech Stocks are Faring? -- Actinium Pharma, Eleven Biotherapeutics, Neuralstem, and

www.prnewswire.com [cached]

Dr. John Pagel of the Swedish Cancer Institute will speak in the Emerging Drugs Showcase session titled, "Radioimmunotherapy in AML: Iomab-B and Actimab-A," on Saturday April 01st, 2017.
Access our complete research report on ATNM for free at:


www.vjhemonc.com

by John Pagel
John Pagel, MD, PhD of the Swedish Cancer Institute, Seattle, WA discusses highlights for chronic lymphocytic leukemia (CLL) from the... 02:55 CLL therapy - current status and issues by John Pagel John Pagel, MD, PhD of the Swedish Cancer Institute, Seattle, WA provides an overview of an educational session on the...


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory